Dapsone and Ddd - a phase IV clinical study of FDA data

Summary:

Ddd is reported as a side effect among people who take Dapsone (dapsone), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Remicade, and have Acute febrile neutrophilic dermatosis.

The phase IV clinical study analyzes which people have Ddd when taking Dapsone. It is created by eHealthMe based on reports of 11,499 people who have side effects when taking Dapsone from the FDA, and is updated regularly.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.

What is Ddd?

Ddd is found to be associated with 1,349 drugs and 1,417 conditions by eHealthMe. Check the latest studies of Ddd.

On Jun, 18, 2026

11,499 people reported to have side effects when taking Dapsone.
Among them, 33 people (0.29%) have Ddd.

Among these 33 people:

How long have people been on Dapsone when they have Ddd? *

What is the gender of people who have Ddd when taking Dapsone? *

female: 78.79 %
male: 21.21 %

What is the age of people who have Ddd when taking Dapsone? *

What are other drugs people take besides Dapsone? *

What are other side effects people have besides Ddd? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 21 people, 63.64%
Rashes (redness): 19 people, 57.58%
Swelling: 18 people, 54.55%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 16 people, 48.48%
Synovial Cyst (cyst of joint filled with synovial fluid): 16 people, 48.48%
Gait Disturbance: 16 people, 48.48%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 48.48%
Nausea (feeling of having an urge to vomit): 16 people, 48.48%
Injection Site Swelling: 15 people, 45.45%
Injection Site Erythema (redness at injection site): 15 people, 45.45%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 48.48%
Acute Febrile Neutrophilic Dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender): 16 people, 48.48%
Multiple Myeloma (cancer of the plasma cells): 6 people, 18.18%
Pain: 5 people, 15.15%
Nausea (feeling of having an urge to vomit): 3 people, 9.09%
High Blood Pressure: 3 people, 9.09%
Cardiac Disorder: 2 people, 6.06%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 6.06%
Headache (pain in head): 2 people, 6.06%
Stress And Anxiety: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Dapsone and have Ddd?

- Check whether Ddd is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dapsone:

Dapsone (11,732 reports)

Ddd treatments and more:

Ddd (19,910 reports)

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ddd:

Ddd (1,349 drugs)

Browse all the conditions that are associated with Ddd:

Ddd (1,417 conditions)

Related publications that referenced our studies

Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on dapsone (the active ingredients of Dapsone) and Dapsone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.